A “lemon-based cold medicine” is currently undergoing trials to combat the spread of the virus, a major breakthrough in the fight against the coronavirus.
Researchers have been working on the anti-viral medicine for years, but the drug could be the first step toward its commercialisation.
It’s been around for over a decade, but was only recently approved by the Food and Drug Administration (FDA).
The drug, called lemon-oil, is made by an Australian company called Takeda.
Its active ingredient is a molecule called thymol, which is also present in the oil of other plants such as parsley, broccoli and carrots.
It’s thought to be a good anti-bacterial, anti-inflammatory and anti-fungal agent.
It is designed to mimic the actions of the immune system, and reduce the production of harmful proteins that cause the virus to spread.
It has the potential to make it easier for people to catch the virus as well as treating people with COVID-19.
Researchers at the National Institutes of Health (NIH) are currently testing the new drug on people who are already infected, but only a small number of people have taken it so far.
However, the research has been praised by health experts, and many believe it could prove useful for those who are currently infected with COID-19, such as pregnant women, people with asthma, and older adults.
There are currently no approved treatments for COVID, but researchers believe it is possible to slow down the spread and reduce symptoms, and potentially save lives.
The drug will be tested on people aged between 40 and 75, and will be given to people as soon as possible.
The research, which has been conducted at the University of Adelaide and the Australian National University, has been supported by the Australian government, and the National Health and Medical Research Council.